Count timea | Treatment group | Dayb | |||||
---|---|---|---|---|---|---|---|
0 | 7 | 14 | 21 | 28 | 35 | ||
8 hours | Placebo | 18.1 | 20.7d | 21.6 | 19.1 | 17.7 | 17.7 |
Simparica Trio™ | 5.9 | 8.0d | 17.1 | 13.9 | 17.1 | 16.8 | |
% Efficacy | 67.5 | 61.5d | 20.6 | 27.3 | 3.1 | 5.0 | |
Test statistic | t(9.71) = 2.19 | t(6.99) = 5.18 | t(40) = 0.84 | t(12.3) = 1.29 | t(13.7) = 0.23 | t(7.68) = 0.75 | |
P-valuec | 0.0545 | 0.0013 | 0.4069 | 0.2191 | 0.8186 | 0.4751 | |
12 hours | Placebo | 21.3 | 23.6 | 18.9 | 21.2d | 24.9 | 19.6 |
Simparica Trio™ | 0.3 | 3.6 | 7.7 | 8.0d | 11.9 | 10.9 | |
% Efficacy | 98.4 | 84.9 | 59.4 | 62.2d | 52.2 | 44.3 | |
Test statistic | t(13.2) = 18.10 | t(9.39) = 6.21 | t(40) = 4.00 | t(6.6) = 4.32 | t(13.8) = 1.79 | t(13.3) = 2.27 | |
P-valuec | < 0.0001 | 0.0001 | 0.0003 | 0.0040 | 0.0957 | 0.0404 | |
24 hours | Placebo | 17.4 | 17.2 | 24.1 | 16.8 | 23.1 | 14.8 |
Simparica Trio™ | 0.1 | 0.1 | 0.0 | 0.3 | 1.3 | 4.8 | |
% Efficacy | 99.4 | 99.4 | 100 | 98.0 | 94.2 | 67.7 | |
Test statistic | t(9.29) = 9.34 | t(9.04) = 11.33 | t(40) = 12.89 | t(9.29) = 7.98 | t(8.03) = 9.62 | t(9.12) = 4.22 | |
P-valuec | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | 0.0022 |